• Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

4332:HK

1,050.000 HKD 364.500 53.17%

As of 04:01:00 ET on 08/28/2014.

Snapshot for Amgen Inc (4332)

Open: 1,050.000 Day's Range: 1,050.000 - 1,050.000 Volume: 100
Previous Close: 685.500 52wk Range: 666.000 - 1,050.000 1-Yr Rtn: -

Stock Chart for 4332

No chart data available.
  • 4332:HK 1,050.000
  • 1D
  • 1M
  • 1Y
685.500
Interactive 4332 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4332

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 16.1710
Relative P/E vs. HSI -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 8.3780
Est. PEG Ratio 1.9551
Market Cap (M HKD) 797,587.59
Shares Outstanding (M) 759.61
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.80%
Cash Dividend (USD) 0.6100
Dividend Ex-Date 08/13/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4332

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 4332

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEODavid W MelineExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Global Commercial OpsBrian M McNameeExec VP:Full Potential Initiatives
More Company Profile & Key Executives for 4332

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil